Introduction to the Impact of Resistance in Hepatitis C
Recorded on February 1, 2017
Sponsored by Abbvie
Drug resistance has become a topic of relevance amongst healthcare providers who care for patients with Hepatitis C. Therefore, it is important that managed care professionals have an understanding of resistance and how it impacts the care of patients. This webinar will provide an introduction to the topic and will answer the following questions:
- How does HCV resistance arise?
- How does a physician test for virologic resistance and interpret results?
- How often should physicians expect to see resistance-associated variants in clinical practice?
- How long do treatment-emergent RAVs persist?
Sammy Saab, MD, MPH, FACG, AGAF, FAASLD
Professor of Medicine and Surgery
Assistant Professor of Nursing
Head, Outcomes Research in Hepatology
David Geffen School of Medicine
This webinar is sponsored, developed and presented by the sponsor. The content of the Science & Innovation Theater Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of the Academy of Managed Care Pharmacy.